The Magazine for Sleep Professionals
Saturday, July 25, 2026
Great Lakes Dental Technologies now offers the Medley Sleep Appliance for patients suffering from sleep apnea and nighttime snoring. The unique Medley appliance features a platform with dual configuration options that can accommodate different advancement mechanisms including rigid nylon links, elastomeric (EMA) straps, or telescopic Herbst®* rod sleeve arms. Medley […]
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death Recalled Product Airway Kit containing Sheridan® Endotracheal Tubes Model numbers: Kit TC7855 Distribution Dates: November 28, 2018 to June 5, 2019 Devices Recalled in […]
Harmony Biosciences, LLC (Harmony) announced yesterday that FDA approved WAKIX®(pitolisant) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy. WAKIX is the first and only treatment approved for patients with narcolepsy that is not scheduled as a controlled substance by the U.S. Drug Enforcement Administration (DEA). […]
Cancer cells thrive in a low oxygen environment. Hospitals will put a patient on oxygen if their O2 levels drop below 92. Untreated Obstructive Sleep Apnea can cause oxygen saturation levels to drop anywhere from the 90s, 80s and even into the 50s. As dentists, you perform extra and intra-oral exams […]
Glidewell Laboratories has added the Oasys Hinge Appliance™ to their dental sleep medicine product line. The device is designed to be comfortable for patients to wear throughout the night. Medicare-approved mandibular advancement device: An estimated 44 million Americans receive Medicare benefits. Due to their age, 65 or over, these patients […]
Two drugs to reduce the scarring of the lungs that occurs in patients with idiopathic pulmonary fibrosis (IPF) appear to increase longevity and decrease hospitalizations, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Clinical Effectiveness of the Anti-Fibrotic Medications […]
DicernaTM Pharmaceuticals, Inc. has announced it submitted a Clinical Trial Authorization (CTA) application to the Swedish Medical Products Agency (MPA) last week to conduct a first-in-human Phase 1/2 study of DCR-A1AT, an investigational therapy from the Company’s GalXC™ technology platform, for the treatment of alpha-1 antitrypsin (A1AT) deficiency-associated liver disease. A1AT […]
Teleflex Incorporated has announced a worldwide recall of certain lots of Hudson RCI® Sheridan® Endotracheal Tubes. The recalled products are designed for oral or nasal intubation and are indicated for airway management. The products involved in this recall are as follows: The U.S. Food and Drug Administration (FDA) has classified […]
By Randy Clare Access to sleep diagnostic services is the limiting factor for dental patients who suspect that they have sleep apnea and require sleep treatment. In recent years, changes to insurance reimbursement and insurance qualification requirements have only made the issue much worse. Dr. Ward Flemons, MD wrote an […]
The Food and Drug Administration (FDA) is advising that rare but serious injuries have happened with certain common prescription insomnia medicines because of sleep behaviors, including sleepwalking, sleep driving, and engaging in other activities while not fully awake. These complex sleep behaviors have also resulted in deaths. These behaviors appear […]
